Press release

07.21.2022

US commercial launch of Curcuwin Ultra+ kicks off with new joint health and mobility study

Read more

03.21.2022

Curcuwin Ultra+ Bioavailability Science Published in Advances in Therapy, Presented at Experimental Biology

Read more

11.17.2021

OmniActive Acquires Global Rights of Award-winning enXtra

Read more

10.05.2021

OmniActive’s Gingever receives self-affirmed GRAS status

Read more

09.28.2021

OmniActive launches Curcuwin Ultra+, ushering in the next gen of highly bioavailable Curcumin

Read more

09.20.2021

OmniActive announces commercial launch of Nutritears for occasional dry eyes

Read more

07.06.2021

OmniActive unveils Integrative Actives platform and introduces Nutritears, a clinically studied formulation to address occasional dry eyes

Read more

05.03.2021

New study shows Xtenergy’s sustained release caffeine profile supports its nootropic benefits

Read more